Gastric secretagogue action of ergot alkaloids in the perfused stomach of anesthetized rats
- PMID: 7084301
- DOI: 10.1016/0014-2999(82)90580-5
Gastric secretagogue action of ergot alkaloids in the perfused stomach of anesthetized rats
Abstract
The gastric secretagogue action of ergot alkaloids was studied in the perfused stomach of anesthetized rats. Ergometrine dose-dependently increased gastric acid secretion and other ergot alkaloids, methysergide, methylergometrine, ergotamine and dihydroergotamine were also found to stimulate gastric secretion. However, Hydergine and bromocriptine did not influence the basal secretion. The gastric secretagogue action of ergometrine was completely inhibited by atropine and was markedly reduced but not abolished by vagotomy. Intraventricular administration of ergometrine produced an increase of acid secretion. Ergometrine did not affect the blood glucose level while insulin decreased it. The effect of ergometrine was not inhibited by serotonin agonistic or dopamine antagonistic agents. These results suggest that some ergot alkaloids have a gastric secretagogue action mainly due to their central effect in anesthetized rats and these actions cannot be explained by serotonin antagonistic, dopamine agonistic and alpha-adrenergic blocking effects of ergot alkaloids. The mechanism of the secretagogue action of ergometrine was different from that of insulin.
Similar articles
-
Bromocriptine, a dopamine D(2) receptor agonist with the structure of the amino acid ergot alkaloids, induces neurite outgrowth in PC12 cells.Eur J Pharmacol. 2008 Nov 19;598(1-3):27-31. doi: 10.1016/j.ejphar.2008.09.015. Epub 2008 Sep 20. Eur J Pharmacol. 2008. PMID: 18835264
-
Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of the rat.Arch Int Pharmacodyn Ther. 1976 Jul;222(1):103-15. Arch Int Pharmacodyn Ther. 1976. PMID: 984962
-
Aggravating effect of ergometrine on pyloric antral lesions in indomethacin-treated animals and stimulating effect of this drug on gastric acid secretion.Jpn J Pharmacol. 1981 Dec;31(6):891-6. doi: 10.1254/jjp.31.891. Jpn J Pharmacol. 1981. PMID: 7334734
-
Pharmacology of ergot alkaloids in clinical use.Med J Aust. 1978 Nov 4;2(3 Suppl):3-13. doi: 10.5694/j.1326-5377.1978.tb77379.x. Med J Aust. 1978. PMID: 370528 Review. No abstract available.
-
Ergot alkaloids. Current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology.Drugs. 1998 Oct;56(4):523-35. doi: 10.2165/00003495-199856040-00002. Drugs. 1998. PMID: 9806101 Review.
Cited by
-
Influence of dopamine receptor agonists on gastric acid secretion induced by intraventricular administration of thyrotropin-releasing hormone in the perfused stomach of anaesthetized rats.Br J Pharmacol. 1983 May;79(1):297-303. doi: 10.1111/j.1476-5381.1983.tb10524.x. Br J Pharmacol. 1983. PMID: 6135480 Free PMC article.
-
Intracerebroventricular injection of a TRH analogue, gamma-butyrolactone-gamma-carbonyl-L-histidyl-prolinamide, induces gastric lesions and gastric acid stimulation in rats.Naunyn Schmiedebergs Arch Pharmacol. 1985 Aug;330(2):142-6. doi: 10.1007/BF00499907. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 3930976
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources